Nanjing Gaoke Co

Nanjing Gaoke Co Enterprise Value

The Enterprise Value (EV) of Nanjing Gaoke Co (600064.SS) as of Nov 4, 2026 is 19.15 B CNY. In the previous year, Enterprise Value (EV) was 19.32 B CNY — a change of -0.90% (lower).

Enterprise Value

19.15 BCNY

YoY

-0.90%

Last updated:

Enterprise Value (EV) of Nanjing Gaoke Co is 2025 19.15 B CNY. Enterprise Value (EV) of Nanjing Gaoke Co was 2024 19.32 B CNY. It decreases by -0.90% lower compared to the previous year.

The Nanjing Gaoke Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
15.51 B CNY
Jan 1, 2019
12.07 B CNY
Jan 1, 2020
14.13 B CNY
Jan 1, 2021
14.99 B CNY
Jan 1, 2022
17.26 B CNY
Jan 1, 2023
18.53 B CNY
Jan 1, 2024
19.32 B CNY
Jan 1, 2025
19.15 B CNY
The Nanjing Gaoke Co Enterprise Value history
YEAREnterprise ValueYoY
19.15 BCNY-0.90%
19.32 BCNY+4.25%
18.53 BCNY+7.38%
17.26 BCNY+15.15%
14.99 BCNY+6.06%
14.13 BCNY+17.12%
12.07 BCNY-22.21%
15.51 BCNY-11.52%
17.53 BCNY+1.42%
17.28 BCNY+2.07%
16.93 BCNY-8.90%
18.59 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanjing Gaoke Co Stock analysis

What does Nanjing Gaoke Co do? Nanjing Gaoke Co., Ltd. generates revenue through its property and municipal business, pharmaceutical operations, and equity investment activities. The company develops residential and commercial properties, manages real estate assets, and provides municipal services in Nanjing, Jiangsu province. Its pharmaceutical business focuses on research, manufacturing, and selling drugs, while equity investments contribute to its income stream. The primary customers for real estate are residents and businesses seeking residential or commercial spaces, and pharmaceutical buyers include healthcare providers and patients in the local market. The company's property and municipal business serves local communities and businesses in Nanjing, Jiangsu, with residential development and property management as key revenue drivers. Pharmaceutical sales target healthcare institutions and end-users within Jiangsu province, leveraging the firm's R&D capabilities. Equity investment activities support diversified income generation without specifying external partners or markets. Nanjing Gaoke's real estate segment includes residential and commercial projects, while its pharmaceutical division handles drug production and distribution. The firm's municipal services integrate with property management to enhance community offerings. Equity investments provide additional financial returns, though specific investment targets are not detailed in the description. Nanjing Gaoke Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanjing Gaoke Co stock

Enterprise Value (EV) of Nanjing Gaoke Co is 19.15 B CNY in 2025.

Enterprise Value (EV) of Nanjing Gaoke Co changed from 19.32 B CNY to 19.15 B CNY, representing a -0.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Nanjing Gaoke Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s CNY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' CNY varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Nanjing Gaoke Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Nanjing Gaoke Co

All Key Metrics — Nanjing Gaoke Co